OverT Bio
Signal active
Organization
Contact Information
Overview
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable immunotherapies, helping the healthcare industry to identify and cure cancer.
About
Industries
Biotechnology, Therapeutics
Founded
2022
Employees
1-10
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
OverT Bio headquartered in New York, New York, United States, North America, operates in the Biotechnology, Therapeutics sector. The company focuses on Biotechnology and has secured $128.0M in funding across 8 round(s). With a team of 1-10 employees, OverT Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - OverT Bio, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
9
Lead Investors
0
Total Funding Amount
$16.0M
Details
1
OverT Bio has raised a total of $16.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed | 16.0M |
Investors
OverT Bio is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| OverT Bio | - | FUNDING ROUND - OverT Bio | 16.0M |
| Wing Venture Capital | - | FUNDING ROUND - Wing Venture Capital | 16.0M |
| OverT Bio | - | FUNDING ROUND - OverT Bio | 16.0M |
| Hawktail Management | - | FUNDING ROUND - Hawktail Management | 16.0M |
Recent Activity
There is no recent news or activity for this profile.